Integra LifeSciences (IART) EVP Hutchinson reports no stock ownership in Form 3

Rhea-AI Filing Summary

Integra LifeSciences Holdings Corp executive Michael Damon Hutchinson filed an initial ownership report showing no securities beneficially owned. The Form 3 identifies him as EVP, Chief Legal Officer and Secretary of Integra LifeSciences, and confirms that, as of the event date, he did not hold any direct or indirect equity or derivative securities of the company.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Hutchinson Michael Damon

(Last) (First) (Middle)

1100 CAMPUS ROAD

(Street)

PRINCETON NJ 08540

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
01/27/2026

3. Issuer Name and Ticker or Trading Symbol
INTEGRA LIFESCIENCES HOLDINGS CORP [ IART ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, Chief Legal Officer & Sec

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

Exhibit 24 - Power of Attorney

No securities are beneficially owned.

	/s/ Lesha Shinn; Attorney-in-Fact for Michael D. Hutchinson	02/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What does the Integra LifeSciences (IART) Form 3 filing for Michael Damon Hutchinson show?

The filing shows that executive Michael Damon Hutchinson currently reports no securities beneficially owned in Integra LifeSciences. It is an initial Form 3 ownership statement, confirming he holds no direct or indirect common stock or derivative securities of the company as of the reported event date.

Who is Michael Damon Hutchinson in relation to Integra LifeSciences (IART)?

Michael Damon Hutchinson is reported as an officer of Integra LifeSciences, serving as EVP, Chief Legal Officer and Secretary. This role is disclosed in the Form 3, which lists his executive position and confirms his status as a reporting person under Section 16 rules.

Does the IART Form 3 indicate that Michael Damon Hutchinson owns any Integra LifeSciences stock?

No, the Form 3 explicitly states that no securities are beneficially owned by Michael Damon Hutchinson. Both the non-derivative and derivative securities tables contain no holdings, and the explanation of responses reiterates that there are currently no beneficially owned securities reported.

What is the significance of a Form 3 filing with no securities owned for IART?

A Form 3 with no securities owned indicates that the executive is newly reporting under insider rules but currently holds no company stock or derivatives. It establishes a baseline ownership position, allowing future Form 4 or Form 5 filings to show any subsequent acquisitions or changes in holdings.

What event date is associated with Michael Damon Hutchinson’s Form 3 for Integra LifeSciences (IART)?

The event requiring the Form 3 statement is dated 01/27/2026. This date marks when Michael Damon Hutchinson’s status as a reporting officer, serving as EVP, Chief Legal Officer and Secretary, triggered the requirement to disclose his initial beneficial ownership position in Integra LifeSciences.

Who signed the IART Form 3 for Michael Damon Hutchinson and in what capacity?

The Form 3 is signed by Lesha Shinn as Attorney-in-Fact for Michael D. Hutchinson. This indicates a power of attorney arrangement, documented as Exhibit 24, authorizing Lesha Shinn to execute the ownership report on Hutchinson’s behalf in compliance with Section 16 reporting requirements.